imported>DaxServer: Add back cat per discussion WP:TCAT using Pywikibot category add

2021-08-22T15:41:14Z

Add back cat per discussion WP:TCAT using Pywikibot category add

New page

{{Short description|Pharmaceutical and biotechnology company headquartered in Mumbai, India}}
{{COI|date=June 2021}}
{{EngvarB|date=January 2014}}
{{Use dmy dates|date=January 2014}}
{{Infobox company
|name = Wockhardt Ltd.
|logo = Wockhardt Logo.png
|type = [[Public company|Public]]
|traded_as = {{NSE|WOCKPHARMA}} {{BSE|532300}}
|foundation = 1960s
|founder = Habil Khorakiwala
|location = [[Mumbai]], [[Maharashtra]], India
|area_served = Worldwide
|key_people = Habil Khorakiwala (Chairman) Murtaza Khorakiwala (managing director) Huzaifa Khorakiwala (Executive Director)
|industry = [[Pharmaceutical]]s Health care
|products = [[Formulation]]s [[Biopharmaceutical]]s Nutrition products [[Vaccine]]s
|revenue = {{loss}} {{INRConvert|2840|c}} (FY 2021)<ref name="FY21">{{cite news |title=Audited Financial Results For The Quarter And Year Ended 31.03.2021 |url=https://www.bseindia.com/xml-data/corpfiling/AttachLive/d047be4a-2ebc-4f64-94c1-a8f67a730091.pdf |access-date=27 May 2021 |work=BSE}}</ref>
|operating_income =
|net_income = {{loss}} {{INRConvert|-296|c}} (FY 2021)<ref name="FY21"/>
|assets =
|equity =
|subsid = [[Wockhardt Hospitals]] Wockhardt Global Schools Wockhardt Foundation
|num_employees = 7,900 (2013)
|homepage = {{url|www.wockhardt.com}}
}}

'''Wockhardt Ltd.''' is a global [[pharmaceutical]] and [[biotechnology]] company headquartered in [[Mumbai]], India. It produces [[formulation]]s, [[biopharmaceutical]]s, nutrition products, [[vaccine]]s and [[active pharmaceutical ingredient]]s (APIs).<ref>{{Cite web|url=http://www.wockhardt.com/about_us.html|title=''ABOUT US'' – Who We Are}}</ref> The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. More than half of its revenue comes from Europe.<ref name="birlaa">{{cite journal|author=Sanju Verma, Amit Shah|year=2007|title=Wockhardt : "Wock"ing the talk...|periodical=HDFC securities|series=India Research|url=http://birlaa.com/wp-filez/Wockhardt%20Company%20Report.pdf}}</ref><ref name=bs>{{cite web|url=http://www.business-standard.com/article/companies/wockhardt-set-to-join-billion-dollar-club-113031900413_1.html |title=Wockhardt set to join billion-dollar club |publisher=Business Standard |date =20 March 2013 |accessdate=20 March 2013}}</ref><ref>{{cite web|url=http://www.wockhardt.com/who-we-are/fact-sheet.aspx |title=Who we are | Fact Sheet |publisher=Wockhardt |accessdate=20 March 2013}}</ref> It has market presence in Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, [[Myanmar]], Sri Lanka, Mauritius, Lebanon and Kuwait.<ref>{{cite web|url=http://www.wockhardt.com/who-we-are/overview.aspx |title=Who we are | Overview |publisher=Wockhardt |accessdate=20 March 2013}}</ref><ref>{{cite web|url=http://www.business-standard.com/stocks/company-overview/8021-wockhardt |title=Wockhardt Ltd – Price, Fundamentals, Charts, Financials |publisher=Business Standard |accessdate=20 March 2013}}</ref> The company employs over 8,600 people globally.<ref>{{cite web|title=Wockhardt Overview|url=http://www.wockhardt.com/who-we-are/overview.aspx|website=Wockhardt|accessdate=13 February 2017}}</ref> [[Wockhardt Hospitals]] is a subsidiary of the Wockhardt Group.<ref>{{Cite web|url=http://www.wockhardt.com/web_sites.html|title=OUR OTHER WEBSITES}}</ref>

==History==
Wockhardt was founded by Dr. Habil Khorakiwala in the 1960s.<ref>{{cite web|title=Wockhardt Chairman's Profile|url=http://www.wockhardt.com/who-we-are/chairmans-profile.aspx|website=www.wockhardt.com|accessdate=13 February 2017}}</ref> His father [[Fakhruddin T. Khorakiwala]] had acquired '''Worli Chemical Works'''<ref>{{cite news|url=http://economictimes.indiatimes.com/Corporate_Dossier/Marginal_business_logic/articleshow/2905713.cms|title=Marginal business logic|author=Priyanka Sangani|work=The Economic Times|date=28 March 2008}}</ref> in 1959. This was incorporated as Wockhardt Pvt. Ltd., in 1973.<ref name="birlaa"/> Wockhardt Ltd. was incorporated on 8 July.1999.<ref>{{cite web|url=http://www.pharmabiz.com/redfr.asp?fn=/comprof/wockhardt.asp |archive-url=https://archive.today/20071020220413/http://www.pharmabiz.com/redfr.asp?fn=/comprof/wockhardt.asp |url-status=dead |archive-date=20 October 2007 |title=Wockhardt Limited |accessdate=9 May 2009 }}</ref> In the 1990s, Wockhardt gained market share with its painkiller proxyvon and blood pressure drug aceton. In 1995, it expanded into [[biotechnology]], and subsequently started producing [[intravenous fluids]].<ref>{{cite web|url=http://timesofindia.indiatimes.com/articleshow/msid-2712332,prtpage-1.cms|author=T. Surendar, Charles Assisi|date=18 January 2008|title='We need a Nano for medicines too'|work=The Times of India}}</ref>

Wockhardt is the first company outside the US and Europe to manufacture [[Recombinant DNA#Synthetic insulin production using recombinant DNA|recombinant human insulin]].<ref>{{cite web|url=http://www.wockhardt.co.uk/aboutus/wockhardtinternational.asp|title=Introducing Wockhardt|accessdate=9 May 2009}}</ref>

During the [[COVID-19 pandemic]], Wockhardt signed a contract with the [[Government of the United Kingdom]] to [[Fill and finish|fill-finish]] the [[Oxford–AstraZeneca COVID-19 vaccine]] at the company's facility in [[Wrexham]], [[Wales]]. The contract was extended until August 2022.<ref>{{cite news |title=UK extends COVID-19 vaccine supply deal with India's Wockhardt by 6 months |url=https://www.livemint.com/news/world/uk-extends-covid-19-vaccine-supply-deal-with-india-s-wockhardt-by-6-months-11612953273999.html |work=Mint |date=2021-02-10 |language=en}}</ref><ref>{{cite news |title=Wockhardt: the company helping to vaccinate Britain |url=https://www.ft.com/content/9e914600-44ad-4901-8ef5-e7a5d2b0b744 |access-date=28 June 2021 |work=Financial Times}}</ref> Wockhardt was also reported to be finalizing a [[Contract manufacturing organization|contract manufacturing]] deal for a vaccine in India.<ref>{{cite news |title=Wockhardt Makes Deal For Mystery Vaccine, Announcement In 2 Weeks |url=https://www.ndtv.com/india-news/wockhardt-makes-deal-for-mystery-vaccine-announcement-in-2-weeks-2455862 |access-date=28 June 2021 |work=NDTV}}</ref>

==Acquisitions and subsidiaries==
Wockhardt's acquisitions include Wallis Laboratory, UK (1998), Merind, India (1998), CP Pharmaceuticals, UK (2003), Espharma GmbH, Germany (2004), [[Dumex]] India (2006), Pinewood Laboratory, Ireland (2006), Morton Grove, US (2007),<ref>{{Cite web|url=https://www.reuters.com/article/idUSBOM9529820071024|title=UPDATE 1-Wockhardt buys US Morton Grove for $38 mln|author=Reuters Staff|date=24 October 2007|via=www.reuters.com}}</ref> and Negma, France (2007).<ref name="birlaa"/> Wockhardt's debt following the acquisitions was close to Rs 38 billion, and Habil Khorakiwala quit as managing director.<ref>{{cite web|url=http://www.business-standard.com/india/news/newsmaker-habil-f-khorakiwala/353842/|title=Newsmaker: Habil F Khorakiwala, Scientist in a hurry|author=Shobhana Subramanian|date=3 April 2009|publisher=Business Standard}}</ref> The board of directors, on 31 March 2009 approved the appointments of Habil Khorakiwala's sons Murtaza Khorakiwala and Huzaifa Khorakiwala as managing director and Executive Director respectively

==Wockhardt Hospitals==
{{main|Wockhardt Hospitals}}
[[Wockhardt Hospitals]] is a tertiary care, super specialty healthcare network in India offering healthcare services. Originally called First Hospitals and Heart Institute, Wockhardt Hospitals was one of the early movers among corporate health-care chains in [[India]]. The company was established in 1989 and started its first operations with a medical center in [[Kolkata]], 1989 and a heart hospital in [[Bangalore]] two years later. The company has its presence across India with 9 multi-specialty hospital networks. This group of 9 hospitals operates in the fields of [[Cardiology]], [[Orthopedics]], [[Neurology]], [[Gastroenterology]], [[Urology]], [[Aesthetics]] and Minimal Access Surgery.{{citation needed|date=July 2020}}

Wockhardt Hospitals was incorporated on 28 August 1991 under the Companies Act, 1956 as a public limited company. In October 2000, the name was changed to Wockhardt Hospitals Limited.{{citation needed|date=July 2020}}

In 2009, Wockhardt Hospitals sold 10 of its hospitals to [[Fortis Healthcare]] for {{INR}}909 crore.<ref>{{cite news |last1=Unnikrishnan |first1=C. H. |title=Wockhardt to sell 10 hospitals to Fortis |url=https://www.livemint.com/Companies/wlYcjJ89sOLhwwmUhu1qtI/Wockhardt-to-sell-10-hospitals-to-Fortis.html |access-date=2021-06-28 |work=mint |date=2009-08-24 |language=en}}</ref>

==References==
{{Reflist}}

==External links==
* [http://www.wockhardt.com/ Official website]
* [https://wockhardtglobalschool.com Wockhardt Global School]

{{Authority control}}

[[Category:Pharmaceutical companies of India]]
[[Category:Manufacturing companies based in Mumbai]]
[[Category:Pharmaceutical companies established in 1960]]
[[Category:Indian companies established in 1960]]
[[Category:1960 establishments in Maharashtra]]
[[Category:Companies listed on the National Stock Exchange of India]]
[[Category:Companies listed on the Bombay Stock Exchange]]

Wockhardt - Revision history

imported>DaxServer: Add back cat per discussion WP:TCAT using Pywikibot category add